SYH2070 injection safety study for high triglycerides and high cholesterol
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your body mass index (BMI) must be between 19 and 30, and you must weigh at least 110 pounds (men) or 99 pounds (women).
- Your fasting triglycerides must be between 150 and 500 mg/dL, and your LDL cholesterol must be between 70 and 190 mg/dL.
- You cannot have taken any medications or supplements that change cholesterol (like statins, fish oil, or fibrates) within at least 30 days before dosing.
- You must be generally healthy, without serious medical conditions, recent major surgery, or infections like hepatitis or HIV.
- You must be willing to keep your diet and exercise habits stable during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
This study tests a new injectable medication (SYH2070) designed to lower cholesterol in people with homozygous familial hypercholesterolemia—a genetic condition that causes extremely high cholesterol levels despite treatment. The goal is to see if this drug safely reduces cholesterol better than current options.
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
This trial tests a new injection (SYH2068) designed to lower lipoprotein(a), a type of cholesterol linked to heart disease. You may qualify if you have high lipoprotein(a) levels and either existing heart disease or significant risk factors for it.
Hear when a new Healthy Subjects (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.